Study compares sleeve gastrectomy with medical treatment in obese patients with type 2 diabetes

April 16, 2012, JAMA and Archives Journals

A study comparing a bariatric surgical procedure with conventional medical treatment in morbidly obese patients with type 2 diabetes mellitus suggests that surgery was associated with remission or improvement in diabetes-related outcomes, according to a report published Online First by Archives of Surgery.

Obesity is one of the major health challenges around the world and the link between obesity and diabetes is well established. The estimates that in 2020 the annual cost of caring for patients with diabetes will approach $192 billion, the authors write in their study background.

Frida Leonetti, M.D., Ph.D., of the Policlinico "Umberto I," University of Rome "Sapienza," Italy, and colleagues conducted a with 30 morbidly with type 2 diabetes (T2DM) who underwent sleeve gastrectomy and 30 others who underwent conventional medical therapy for their diabetes.

In the group of patients who underwent laparoscopic sleeve gastrectomy (LSG), "remission of diabetes, as already defined according to the criteria adopted by Buse et al, was achieved for 24 of 30 patients (80 percent), for all 20 patients (100 percent) with a T2DM duration of less than 10 years, and for four of 10 of patients with a T2DM duration more than 10 years (40 percent)," the authors comment in the study results.

All the patients treated with conventional medical therapy remained diabetic and continued or increased their level of hypoglycemic therapy, according to the results.

The group that underwent surgery had a mean (average) (BMI) of 41.3 preoperatively that declined to 28.3 at 18 months postoperatively. The other group had a mean preoperative BMI of 39 and a postoperative BMI of 39.8 after 18 months, the study results indicate.

In the surgical group, the prevalence of obstructive sleep apnea (OSAS) decreased from 50 percent to 10 percent and medication use also decreased at 18 months for and hypolipemic (cholesterol-lowering) medications. The prevalence of OSAS did not change in the non-surgical group and medication use increased, although not significantly, for antihypertensive and hypolipemic medications, according to the results.

"Midterm and long-term results are needed to confirm the positive effect (remission and/or improvement) of LSG on and, overall, on the chronic complications of the disease," the authors conclude. "Most importantly, the longer-term results will allow us to compare the costs and benefits of bariatric surgery vs conventional medical treatments."

In an invited critique, Jon C. Gould, M.D., of the Medical College of Wisconsin, Milwaukee, writes: "This is a nice contribution, but, by now, this kind of outcome should not come as a surprise to any bariatric surgeon or regular reader of the ."

"These findings demonstrate to the bariatric community that there is a great opportunity to partner with primary care physicians and to educate the public on the significant benefits and safety of bariatric surgery. National guidelines for bariatric surgery need to be developed for people with and a body mass index of 35 or more (calculated as weight in kilograms divided by height in meters squared)," Gould continues.

Gould concludes: "An obese diabetic patient should have access to bariatric surgery in appropriate clinical circumstances. This access should be uniform, consistent, and not subject to potential bias, differences in opinion, or a lack of understanding regarding contemporary bariatric outcomes."

Explore further: Bariatric surgery dramatically outperforms standard treatment for type 2 diabetes

More information: Arch Surg. Published online April 16, 2012. doi:10.1001/archsurg.2012.222
Arch Surg. Published online April 16, 2012. doi:10.1001/archsurg.2012.227

Related Stories

Bariatric surgery dramatically outperforms standard treatment for type 2 diabetes

March 26, 2012
In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery dramatically outperforms ...

Bariatric surgery among older, high-risk patients not associated with reduced mortality

June 13, 2011
The use of bariatric surgery among older, severely obese patients was not associated with a decreased risk of death, according to a study in the June 15 issue of JAMA. This study is being released early online to coincide ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.